Navigation Links
Cell Therapeutics Announces Final Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding
Date:6/19/2009

SEATTLE, June 19 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (the "Company" or "CTI") (Nasdaq and MTA: CTIC) today announced the final results of its separate concurrent fixed price exchange offers (each, an "Exchange Offer" and together, the "Exchange Offers") for any and all of the approximately $118.9 million outstanding principal amount of five series of its convertible notes (the "Notes"). The Exchange Offers expired at 5:00 p.m., New York City time, on Tuesday, June 16, 2009.

In accordance with the terms and conditions of the Exchange Offers, and based on the final count by U.S. Bank National Association, the depositary for the Exchange Offers, the Company has accepted for exchange approximately $52.9 million aggregate principal amount of the Notes for the previously announced exchange consideration of (i) $134.50 cash, and (ii) 458 shares of common stock per $1,000 principal amount of Notes validly tendered and not withdrawn in each Exchange Offer, for a total amount of exchange consideration (excluding interest, fees and other expenses in connection with the Exchange Offers) of approximately $7.1 million cash and approximately 24.2 million shares of common stock.

The $1.9 million reduction in the final aggregate principal amount of Notes accepted for exchange compared to the preliminary aggregate principal amount of Notes tendered for exchange announced by the Company on June 17, 2009 is due to the depositary's receipt of separate notices of guaranteed delivery from two different brokers for the same Notes.

As a result of this transaction, the Company will eliminate approximately $52.9 million of debt, reduce its annual interest expense by approximately $3.3 million, and increase its shareholder's equity by approximately $43.7 million. In addition, the Company expects to book an estimated gain on the exchange of approximately $7.9 million.

The Company has accep
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Prime Therapeutics Receives TIPPS Certification
2. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
3. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
4. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
5. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
6. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
7. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
8. Prime Therapeutics Announces URAC Accreditation
9. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
10. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
11. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...v. 6 Centene Corporation (NYSE: CNC ) today anno...are conferences over the next few weeks. ,, Next w...Conference, to be held November 11-13, 2009, at th...ene will present Wednesday, November 11th at 4:30 ... parties may access Centene,s presentation at: h...
(Date:11/6/2009)...ov. 6 The U.S. bishops sent an urgent message to ...ouse members steeped themselves in debate over pro...form bill. ,, Moments before meeting to discuss pr...for "a fair process" that would permit discussion ...law on abortion funding and conscience protections...
(Date:11/6/2009)...Ill., Nov. 6 Hospira, Inc. (NYSE: HSP ), a leadi...delivery company, today announced that the company...lth Care Conference on Wednesday, Dec. 2, 2009 in ... begin at 9:30 a.m. Eastern time on Wednesday, Dec... parties through a live audiocast accessible via t...
(Date:11/6/2009)...rease, so does the need to exert more pressure fro...ov. 6 (HealthDay News) -- Hormonal fluctuations ma... new study finds. , Many professional singers hav... been known whether this was because of hormones o... the baby grows. , In this study, researchers foll...
(Date:11/6/2009)...could provide new lung tissue for certain patients...thDay News) -- Belgian scientists who used embryon...ique could provide an alternative to lung transpla...ry disease (COPD) and cystic fibrosis. , This is t...cells can be converted into airway epithelial-like...
Breaking Medicine News(10 mins):Health News:Centene Corporation to Present at Upcoming Healthcare Conferences 2Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 2Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 3Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 4Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 5
... PhD, have collaborated for 20 years to help build...arrow Neurological Institute at St. Joseph,s Hospi...atient care and research, the Shapiros have establ...ow to hire the best and the brightest to carry on ...
...amp; Hair Replacement Center, Hair Fantasy, LLC is...ices for clients battling with hair loss, thinning...nbelt, MD (PRWEB) February 27, 2009 -- There are s... effects from medication, iron or zinc deficiency ...
...ealthier, More Productive Practice , , NEWBERG, O...ration of technology and is well-positioned to fit...dec 300 system offers customers a mid-level platfo...(Photo: http://www.newscom.com/cgi-bin/prnh/2009...
...Care and Ophthalmics Business of Unomedical Ltd. ,...are Partners ("RoundTable"), an operating-oriented...althcare industry, announced today that its portfo... ("Unomedical") based in Redditch, U.K. Unomedical...
...nical research organization announced today that i...ector, Late Phase, Europe. , , Ms. Turner bring...in Chiltern,s global Late Phase Organization. Ms. ... side of management in both industries. In her mos...
... that would require nutrition information on chain... hold a news conference at noon on Tuesday in Anna...g on the measure will be held in the House Health ...r Michelle Forman , American Diabetes Association ...
Other Medicine News:Health News:A lifetime of paying it forward 2Health News:Inspired Cancer Survivor Launches Customized Hair Replacement ,Techniques at Award-Winning Hair Salon 2Health News:New A-dec 300(TM) Offers Dentists an Innovative Equipment Solution 2Health News:RoundTable Healthcare Partners Leads Portfolio Company Add-On Acquisition 2Health News:RoundTable Healthcare Partners Leads Portfolio Company Add-On Acquisition 3Health News:Chiltern Appoints Jane Turner as Late Phase Director for Europe 2
(Date:11/6/2009)... Nov. 6 The ,Help is ...arolina and Georgia throughout the week of Novembe...d and financially-struggling patients access infor...ines for free or nearly free. With the nation,s un...nership for Prescription Assistance (PPA) bus tour...
(Date:11/6/2009)...Nov. 6 Derma Sciences,...advanced wound care products, announced plans to r...t on Monday, November 16, 2009. The Company will h... results at 11:00 am EST. Interested parties shoul... (international), with passcode 81416481 to access...
(Date:11/6/2009)... NuVasive, Inc. (Nasdaq:...loping products for minimally disruptive surgical ...intment of Michael J. Lambert as Executive Vice Pr...ember 9, 2009. The Company also announced several...ichael will be an excellent complement to the NuVa...
Breaking Medicine Technology:Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 2Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 3Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 4NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 5Biopure Files Voluntary Petition for Relief Under Chapter 11 of the United States Bankruptcy Code 51960 1Nile Therapeutics Inc Completes 243 4 Million Private Placement 13072 1Nile Therapeutics Inc Completes 243 4 Million Private Placement 13072 2Nile Therapeutics Inc Completes 243 4 Million Private Placement 13072 3Chinese Drywall Litigation 26 Insurance Conference July 28 in San Francisco 51957 1Chinese Drywall Litigation 26 Insurance Conference July 28 in San Francisco 51957 2
...t-Aid Kits Of Relief Organizations to Mark 110th ...WN, N.J., Aug. 2 The Roman Coliseum, the Taj,Maha... national survey, 74,percent of Americans believe ...ther Wonders of the World. It,s no wonder, of cour...ll has made "monumental" contributions to,mankind,...
...linical Trials Initiated with Teplizumab Manufactu...ROCKVILLE, Md., Aug. 2 MacroGenics, Inc. announce...ng adults and children ages,8 to 35 with recent-on...,trial will evaluate the safety and efficacy of th... start of the study and again at six months in,ind...
Other Medicine Technology:Aspirin Named 8th World Wonder by Majority of Americans 2Aspirin Named 8th World Wonder by Majority of Americans 3Aspirin Named 8th World Wonder by Majority of Americans 4MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus 2MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus 3MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus 4
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
Medicine Products: